Principal Investigator
Sangeetha Venugopal
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250687
Clinical Trial Summary
A Phase 2, Randomized, Open-label, Study of Momelotinib in Participants with Anemia due to Low-risk Myelodysplastic Syndrome.
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Leukemia
Contact Information
Phone Number
305-243-2647